AtriCure, Inc. (ATRC): Price and Financial Metrics


AtriCure, Inc. (ATRC): $45.56

-0.40 (-0.87%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

ATRC POWR Grades

  • ATRC scores best on the Growth dimension, with a Growth rank ahead of 78.36% of US stocks.
  • ATRC's strongest trending metric is Sentiment; it's been moving up over the last 178 days.
  • ATRC's current lowest rank is in the Quality metric (where it is better than 16.22% of US stocks).

ATRC Stock Summary

  • With a price/sales ratio of 6.77, ATRICURE INC has a higher such ratio than 83.21% of stocks in our set.
  • ATRC's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of just 17.3% of US stocks.
  • Over the past twelve months, ATRC has reported earnings growth of -201.36%, putting it ahead of only 7.72% of US stocks in our set.
  • If you're looking for stocks that are quantitatively similar to ATRICURE INC, a group of peers worth examining would be GLBE, AXGN, VSAT, EXAS, and VCYT.
  • ATRC's SEC filings can be seen here. And to visit ATRICURE INC's official web site, go to www.atricure.com.

ATRC Valuation Summary

  • ATRC's price/sales ratio is 6.7; this is 34% higher than that of the median Healthcare stock.
  • ATRC's price/earnings ratio has moved down 252.7 over the prior 211 months.

Below are key valuation metrics over time for ATRC.

Stock Date P/S P/B P/E EV/EBIT
ATRC 2022-12-02 6.7 4.7 -37.8 -41.8
ATRC 2022-12-01 6.8 4.7 -38.1 -42.1
ATRC 2022-11-30 6.7 4.7 -37.8 -41.8
ATRC 2022-11-29 6.4 4.5 -36.1 -39.9
ATRC 2022-11-28 6.5 4.5 -36.4 -40.2
ATRC 2022-11-25 6.8 4.7 -38.0 -42.0

ATRC Growth Metrics

    The year over year revenue growth rate now stands at 36.24%.
  • The 3 year cash and equivalents growth rate now stands at 35.82%.
  • Its 2 year net cashflow from operations growth rate is now at -57.62%.
ATRC's revenue has moved up $72,436,000 over the prior 15 months.

The table below shows ATRC's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 315.569 -21.886 -56.037
2022-06-30 302.783 -20.334 53.343
2022-03-31 289.63 -29.096 51.933
2021-12-31 274.329 -13.78 50.199
2021-09-30 258.836 -10.127 45.378
2021-06-30 243.133 -6.083 -56.679

ATRC's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • ATRC has a Quality Grade of C, ranking ahead of 28.8% of graded US stocks.
  • ATRC's asset turnover comes in at 0.344 -- ranking 124th of 186 Medical Equipment stocks.
  • INGN, BSX, and GKOS are the stocks whose asset turnover ratios are most correlated with ATRC.

The table below shows ATRC's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.344 0.746 -0.169
2021-03-31 0.301 0.729 -0.142
2020-12-31 0.311 0.723 -0.152
2020-09-30 0.337 0.722 -0.163
2020-06-30 0.361 0.722 -0.213
2020-03-31 0.463 0.736 -0.227

ATRC Price Target

For more insight on analysts targets of ATRC, see our ATRC price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $96.71 Average Broker Recommendation 1.31 (Strong Buy)

ATRC Stock Price Chart Interactive Chart >

Price chart for ATRC

ATRC Price/Volume Stats

Current price $45.56 52-week high $74.85
Prev. close $45.96 52-week low $32.51
Day low $43.80 Volume 132,600
Day high $46.02 Avg. volume 273,109
50-day MA $40.83 Dividend yield N/A
200-day MA $48.04 Market Cap 2.12B

AtriCure, Inc. (ATRC) Company Bio


Atricure provides atrial fibrillation solutions worldwide. The Company has three primary product lines for cardiac tissue ablation and a product line for left atrial appendage exclusion. The company was founded in 2000 and is based in West Chester, Ohio.


ATRC Latest News Stream


Event/Time News Detail
Loading, please wait...

ATRC Latest Social Stream


Loading social stream, please wait...

View Full ATRC Social Stream

Latest ATRC News From Around the Web

Below are the latest news stories about ATRICURE INC that investors may wish to consider to help them evaluate ATRC as an investment opportunity.

AtriCure to Present at 34th Annual Piper Sandler Healthcare Conference

MASON, Ohio, November 08, 2022--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today announced that the company will present at the 34th Annual Piper Sandler Healthcare Conference.

Yahoo | November 8, 2022

AtriCure (ATRC) Reports Q3 Loss, Tops Revenue Estimates

AtriCure (ATRC) delivered earnings and revenue surprises of -8% and 2.26%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | November 1, 2022

AtriCure Reports Third Quarter 2022 Financial Results

MASON, Ohio, November 01, 2022--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today announced third quarter 2022 financial results.

Yahoo | November 1, 2022

Will Nephros Inc. (NEPH) Report Negative Earnings Next Week? What You Should Know

Nephros Inc. (NEPH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Yahoo | October 26, 2022

Analysts Estimate AtriCure (ATRC) to Report a Decline in Earnings: What to Look Out for

AtriCure (ATRC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Yahoo | October 25, 2022

Read More 'ATRC' Stories Here

ATRC Price Returns

1-mo 14.91%
3-mo 6.40%
6-mo 8.24%
1-year -30.12%
3-year 46.92%
5-year 155.81%
YTD -34.47%
2021 24.90%
2020 71.24%
2019 6.24%
2018 67.76%
2017 -6.80%

Continue Researching ATRC

Here are a few links from around the web to help you further your research on AtriCure Inc's stock as an investment opportunity:

AtriCure Inc (ATRC) Stock Price | Nasdaq
AtriCure Inc (ATRC) Stock Quote, History and News - Yahoo Finance
AtriCure Inc (ATRC) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 1.0068 seconds.